FDA Import Alert 54-15
Red List Expansion, 2022-Present
In February 2022, the FDA expanded Import Alert 54-15 to cover all kratom products. This "Red List" designation allows detention without physical examination—and it's reshaping the American kratom supply chain.
What Is a Red List Import Alert?
Import Alerts are FDA enforcement tools. Red List means:
- All shipments from listed manufacturers/exporters are subject to Detention Without Physical Examination (DWPE)
- Product can be held at port indefinitely
- Vendor must provide independent lab testing to "green list" the shipment
- Costs $10,000-$50,000 per detention in storage and testing fees
Why Kratom Was Added
The FDA cites:
- Salmonella contamination (2018 outbreak linked to 199 cases)
- Heavy metals (lead, nickel)
- Unapproved new drug claims (vendors marketing for specific conditions)
- Adulteration with O-desmethyltramadol (historical, not current)
Small vendors without legal teams have exited the market. Remaining vendors use "workarounds"—importing as "incense" or "research material" (legally risky), or paying premium prices for GMP-certified Indonesian suppliers who can provide FDA-acceptable documentation.
What Consumers Should Know
- Stock issues: Vendor outages often trace to detained shipments
- Price increases: Compliance costs passed to consumers
- Quality variance: Desperate vendors may source untested material
- The KCPA solution: State-level regulation provides framework for FDA compliance
The AKA is working with FDA to establish a "green channel" for GMP-certified kratom—similar to the system for dietary supplements. Support the KCPA to create regulated pathways for safe importation.
Source: FDA Import Alert 54-15 (official document); American Kratom Association regulatory updates (2022-2024).